Search clinical trials for: ERX-963
Total 1970 results
-
Expansion Therapeutics, Inc.CompletedMyotonic Dystrophy | Myotonic Dystrophy, Type 1 (DM1)United States
-
Trygg Pharma, Inc.UnknownSevere HypertriglyceridemiaUnited States
-
University of California, Los AngelesCompleted
-
Novartis PharmaceuticalsTerminatedHealthy VolunteersUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Unknown
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
TaiRx, Inc.CompletedAdvanced CancerTaiwan
-
University of ChicagoNational Institute on Aging (NIA)Enrolling by invitation
-
TakedaCompleted
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs SyndromeJapan
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
AbbVieCompletedHealthy VolunteerUnited States
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma LPCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
AbbVieTerminatedHealthy VolunteersUnited States
-
AbbVieNot yet recruiting
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma LPCompleted
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
Athos Therapeutics IncSyneos Health; Athos Therapeutics Australia Pty LtdCompletedAutoimmune Diseases | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisAustralia
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Gilead SciencesCompleted
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma, CanadaCompleted
-
Revibe TechnologiesCompleted
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Avanir PharmaceuticalsCompletedMultiple SclerosisUnited States
-
Molecular NeuroImagingCompletedHealthy VolunteersUnited States
-
GlaxoSmithKlineCompletedMuscular DystrophiesGermany, Belgium, Turkey, Netherlands, Spain, Israel, Australia, France, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
Merck Sharp & Dohme LLCCompleted
-
Utah State UniversityUniversity of North Carolina, Chapel Hill; International OCD FoundationCompletedObsessive-Compulsive DisorderUnited States
-
TakedaCompletedSchizophreniaUnited States
-
PfizerTerminatedCachexiaUnited States
-
CelltrionCompletedSARS-CoV-2 InfectionPoland
-
University of California, San DiegoCompletedChronic Lymphocytic LeukemiaUnited States
-
Mclean HospitalUtah State UniversityCompleted
-
Acotec Scientific Co., LtdZhejiang UniversityCompletedVaricose Veins of Lower LimbChina
-
Baylor College of MedicineWithdrawn
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Maculaser OyCompletedHealthy | Macular Degeneration | Macular EdemaFinland
-
UCB PharmaCompleted
-
Johns Hopkins UniversityNational Institutes of Health (NIH); National Library of Medicine (NLM)Completed
-
Mediar TherapeuticsICON plcRecruiting
-
Sangamo TherapeuticsTerminatedMucopolysaccharidosis II | MPS IIUnited States
-
Oslo University HospitalGöteborg University; Sahlgrenska University Hospital, SwedenCompletedAneurysmal Subarachnoid HemorrhageNorway